Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1963 1
1972 2
1973 3
1974 1
1975 6
1976 2
1977 1
1980 2
1982 2
1983 1
1984 2
1985 3
1987 2
1989 5
1990 3
1991 5
1992 9
1993 15
1994 10
1995 6
1996 7
1997 3
1998 3
1999 8
2000 5
2001 14
2002 14
2003 15
2004 19
2005 18
2006 32
2007 30
2008 23
2009 24
2010 35
2011 68
2012 81
2013 71
2014 72
2015 67
2016 68
2017 58
2018 50
2019 47
2020 80
2021 108
2022 103
2023 65
2024 77
2025 55

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,236 results

Results by year

Filters applied: . Clear all
Page 1
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
Liou JM, Jiang XT, Chen CC, Luo JC, Bair MJ, Chen PY, Chou CK, Fang YJ, Chen MJ, Chen CC, Lee JY, Yang TH, Yu CC, Kuo CC, Chiu MC, Chen CY, Shun CT, Hu WH, Tsai MH, Hsu YC, Tseng CH, Chang CY, Lin JT, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Liou JM, et al. Among authors: yu cc. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):228-241. doi: 10.1016/S2468-1253(22)00384-3. Epub 2022 Dec 19. Lancet Gastroenterol Hepatol. 2023. PMID: 36549320 Clinical Trial.
Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer.
Hsu FT, Chen YT, Chin YC, Chang LC, Chiang SC, Yang LX, Liu HS, Yueh PF, Tu HL, He RY, Jeng LB, Shyu WC, Hu SH, Chiang IT, Liu YC, Chiu YC, Wu GC, Yu CC, Su WP, Huang CC. Hsu FT, et al. Among authors: yu cc. ACS Nano. 2024 Oct 22;18(42):28764-28781. doi: 10.1021/acsnano.4c07903. Epub 2024 Oct 9. ACS Nano. 2024. PMID: 39383310
1,236 results